10/29
08:30 am
lsb
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
10/29
08:30 am
lsb
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
10/25
08:30 am
lsb
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
Low
Report
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
10/25
08:30 am
lsb
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
Low
Report
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
10/8
08:30 am
lsb
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
Medium
Report
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
10/8
08:30 am
lsb
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
Medium
Report
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
9/27
07:00 am
lsb
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
Low
Report
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
9/27
07:00 am
lsb
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
Low
Report
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
9/10
08:00 am
lsb
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
Low
Report
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
9/10
08:00 am
lsb
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
Low
Report
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
9/4
08:00 am
lsb
LakeShore Biopharma Announces Leadership Transitions
Medium
Report
LakeShore Biopharma Announces Leadership Transitions
9/4
08:00 am
lsb
LakeShore Biopharma Announces Leadership Transitions
Medium
Report
LakeShore Biopharma Announces Leadership Transitions